Myriad Genetics, Inc. (MYGN) ownership: Glenview Capital Management 7% · institutions 225% (13F 2026-03-31). Insider activity, 90 days: Routine (1 sales, 0 open-market buys). SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| Orbimed Advisors LLC | 125000000.00 | $122.88M | 130.7% | 2026-03-31 |
| BlackRock | 8889644.00 | $40.00M | 9.3% | 2026-03-31 |
| Vanguard | 7402812.00 | $33.31M | 7.7% | 2026-03-31 |
| Millennium Management | 6668817.00 | $30.01M | 7.0% | 2026-03-31 |
| Glenview Capital Management, LLC | 5411978.00 | $24.35M | 5.7% | 2026-03-31 |
| D. E. Shaw | 4499724.00 | $20.25M | 4.7% | 2026-03-31 |
| State Street | 4424027.00 | $19.91M | 4.6% | 2026-03-31 |
| Morgan Stanley | 3168742.00 | $14.26M | 3.3% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-16 | |
| Sell | null | 2026-06-23 | |
| Sell | null | 2026-06-23 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-08 | |
| Sell | null | 2026-06-04 | |
| Sell | null | 2026-06-04 |
Back to MYGN overview · MYGN earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.